Ep. 10: Medical Cannabis Revisited: What Clinicians Need to Know in 2026
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Ep. 10: Medical Cannabis Revisited: What Clinicians Need to Know in 2026
-
ナレーター：
-
著者：
Medical cannabis returns to Psychopharmacology Today, reflecting the rapidly evolving legal, scientific, and clinical landscape surrounding cannabis use. Drawing on a newly revised version of his popular webinar, Dr. Randall Tackett examines what clinicians need to know in 2026 as more patients use cannabis-derived products and more states expand medical cannabis access.
Separating evidence from misinformation, Dr. Tackett reviews the pharmacology of cannabinoids, including THC, CBD, and newer hemp-derived compounds such as Delta-8 and Delta-10 THC. He explains the therapeutic evidence supporting approved cannabinoid medications, discusses where research remains limited, and highlights emerging concerns involving product labeling, drug testing, driving impairment, employment, and the unintended consequences of hemp-derived cannabinoid products following the 2018 Farm Bill. Throughout the episode, listeners gain a practical, evidence-based framework for evaluating the benefits, risks, and limitations of medical cannabis in ever-evolving contemporary clinical practice.